Skip to content
ProPublica Donate
ProPublica Donate
Photo of Debbie Cenziper

Debbie Cenziper

I write about national issues, from housing to health care, and the agencies most responsible for the welfare of Americans.

Have a Tip for a Story?

I welcome tips from anyone familiar with the FDA and issues involving drug safety, medical device safety and health care.

What I Cover

I am interested in issues related to the Food and Drug Administration and spent 2023 investigating the massive recall of breathing machines by Philips Respironics. I have also written extensively about affordable housing programs. I’ve helped lead international projects and was one of the lead reporters at The Washington Post on the award-winning “Pandora Papers” investigation, a 2021 report about the secret movement of wealth around the world. In 2022, while at ProPublica, I co-authored “Shadow Diplomats,” an investigation about troubled volunteer diplomats that has spurred reforms in nine countries.

My Background

I am a Pulitzer Prize-winning investigative reporter and nonfiction author who spent more than a decade at the Post. Over 30 years, my stories have changed laws, prompted congressional and FBI investigations, and helped secure more funding for affordable housing, mental health care and public schools. I’ve won dozens of journalism awards, including the Pulitzer Prize for local reporting about corrupt affordable housing developers in Miami. I am the author of “Citizen 865: The Hunt for Hitler’s Hidden Soldiers in America” and “Love Wins: The Lovers and Lawyers Who Fought the Landmark Case for Marriage Equality,” named one of the most notable books of the year by the Post. I am also a professor at the Medill School of Journalism at Northwestern University.

Rx Roulette

FDA Layoffs Could Compromise Safety of Medications Made at Foreign Factories, Inspectors Say

Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked with rooting out dangerous manufacturing practices.

Rx Roulette

Seven Things to Know About ProPublica’s Investigation of the FDA’s Secret Gamble on Generic Drugs

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These are the key takeaways.

Rx Roulette

His Kidney Failed. He’ll Never Know if a Transplant Drug From a Banned Factory Was to Blame.

When Joe DeMayo’s donated kidney started to fail earlier than expected, he didn’t know that the drug he was taking could’ve left him vulnerable — and that one of the most formidable drug regulators in the world may have failed to protect him.

Rx Roulette

Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs

A ProPublica investigation found that for more than a decade, the FDA gave substandard factories banned from the United States a special pass to keep sending drugs to an unsuspecting public.

Rx Roulette

We Spent a Year Investigating How the FDA Let Risky Drugs Into the U.S. Market

Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into the U.S. over the past dozen years even though they were made at factories banned from shipping their products here.

Unsanitary Practices Persist at Baby Formula Factory Whose Shutdown Led to Mass Shortages, Workers Say

“Persistent leaks” and “unaddressed contamination issues” are among the problems workers say they witnessed at one of the nation’s largest baby formula plants. “I can’t have this on my conscience,” one told ProPublica

The FDA Hasn’t Inspected This Drug Factory After 7 Recalls for the Same Flaw, 1 Potentially Deadly

Glenmark Pharmaceuticals issued seven recalls for pills that didn’t dissolve properly, records show. All were made at the same factory in India. But the FDA still hasn’t stopped the company from shipping other pills made there to the U.S.

With Every Breath

Philips Agrees to Pay $1 Billion to Patients Who Say They Were Injured by Breathing Machines

The proposed settlement will effectively end more than 700 lawsuits filed after the 2021 recall of millions of the company’s widely used sleep apnea devices and ventilators.

With Every Breath

Amid Recall Crisis, Philips Agrees to Stop Selling Sleep Apnea Machines in the United States

The breathing machine manufacturer has faced relentless criticism over its handling of the 2021 recall of millions of devices. Philips must meet the requirements outlined in an agreement with the Justice Department before it can resume sales.

With Every Breath

Congressional Watchdog Will Launch Inquiry Into FDA Oversight of Medical Device Recalls

Sens. Dick Durbin and Richard Blumenthal asked the Government Accountability Office to investigate the regulatory agency, citing ProPublica and Pittsburgh Post-Gazette reports on the 2021 recall of Philips breathing machines.